Amberstone Biosciences
Laguna Hills, US · Delaware corporation
Biotech
Founders & leadership
GG
George Guikai WuExecutive Officer, Director
YG
Yonglei Guikai ShangExecutive Officer, Director
WG
Weian Guikai ZhaoDirector
Reported raises · per SEC filings
Form D private placements▶$6MraisedDec 2021 · 6 investors · BiotechnologyRule 506(b)
Officers, directors & promoters on the filing
- George Guikai WuExecutive Officer, Director
- Yonglei Guikai ShangExecutive Officer, Director
- Weian Guikai ZhaoDirector
- Offering amount
- $12M
- Amount sold
- $6M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.